We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook......
(read more)December 7 - Hedge Funds, News - Comments
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due......
(read more)October 22 - Hedge Funds, News - Comments
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred......
(read more)June 10 - Hedge Funds, News - Comments
“October lived up to its scary reputation—the S&P 500 falling in the month by the largest amount in the last 40 years, the only worse Octobers......
(read more)March 30 - Hedge Funds, News - Comments
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on......
(read more)December 9 - Hedge Funds, News - Comments
Warren Buffett is arguably the greatest investor of all time. Over his career, Buffett’s investing prowess formed one of the greatest conglomerates......
(read more)November 12 - News - Comments
SunPower Corporation (NASDAQ:SPWR) (The Motley Fool) What happened: Shares of solar manufacturer SunPower Corp. (NASDAQ:SPWR) fell as much as 12.4% in......
(read more)February 15 - Market Movers, News - Comments
Twitter Inc (NYSE:TWTR) (MarketWatch) Twitter Inc. TWTR, +15.64% shares soared 12.6% in premarket trading after the company delivered better-than-expected......
(read more)February 8 - Market Movers, News - Comments
In this article we are going to share highlights from Jana Partners’ 2017 Q4 investor letter. JANA Master Fund returned 5.6% net of fees and expenses......
(read more)January 25 - Hedge Fund Investor Letters, Hedge Funds, News - Comments
The top 10 generic pharmaceutical companies in 2017 operate in the relatively recession-proof pharmaceuticals industry which is immune from the vagaries......
(read more)December 13 - Lists, News - Comments
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in. These......
(read more)July 17 - Dividend Stocks, News - Comments
1. U.S. Stock Market: “U.S. equities traded higher on Wednesday as investors cheered the Federal Reserve’s plan for scaling back its massive......
(read more)May 24 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has unveiled the authorized generic version of Minastrin, an oral contraceptive that is combined......
(read more)March 20 - News, Stock Analysis - Comments
David Tepper of Appaloosa Management is one of the most closely followed hedge fund managers in the world. The outspoken billionaire investor is candid......
(read more)March 13 - Hedge Fund Analysis, Hedge Funds, News - Comments
The number of states accusing Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Mylan N.V. (NASDAQ:MYL) for price collusion have risen as the list......
(read more)March 2 - News, Stock Analysis - Comments
An application for a new drug by Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has been accepted by the Food and Drug Administration. Teva’s......
(read more)March 1 - News, Stock Analysis - Comments
What are the 10 states with the highest opioid abuse rates? Opioid pain killers are generally a good thing. Without them, many patients would suffer substantially......
(read more)February 26 - Lists, News - Comments
Back in 2008, billionaire Warren Buffett made a bet that hedge funds will underperform index funds over the following decade. While the bet still has......
(read more)February 23 - Activism, Hedge Funds, News - Comments
Pfizer Inc. (NYSE:PFE) has been slapped with a warning letter by the Food and Drug Administration in regards to one of its fill/finish factories. This......
(read more)February 22 - News, Stock Analysis - Comments
Notable value investor and billionaire Michael Price recently has revealed his equity portfolio as of the end of 2016 via a 13F filing submitted with......
(read more)February 20 - Hedge Funds, News - Comments
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has announced the approval of AirDuo RespiClick and ArmonAir RespiClick by the U.S. Food and Drug......
(read more)February 2 - News, Stock Analysis - Comments
A U.S. court has rejected four claims of patent infringement from Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA). The asserted claims involved the......
(read more)January 31 - News, Stock Analysis - Comments
Patients with severe pain that demands long-term, around-the-clock treatment now have a new medication to try. They will now be able to use Vantreal ER......
(read more)January 19 - News, Stock Analysis - Comments
Brower Piven, a law firm specializing in securities litigation, is sending out an appeal reminding investors of Teva Pharmaceutical Industries Ltd (ADR......
(read more)December 30 - News, Stock Analysis - Comments
The Securities and Exchange Commission has revealed that Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) will have to pay more than $500 million......
(read more)December 28 - News, Stock Analysis - Comments
Billionaire Michael Price is an American value investor and hedge fund manager who founded MFP Investors, a New York-based investment fund, in 1988. Mr......
(read more)December 22 - Hedge Funds, News - Comments
John Paulson founded New York-based investment management firm Paulson & Company in 1994. He shot into prominence when he earned almost $4 billion......
(read more)December 17 - Hedge Fund Analysis, Hedge Funds, News - Comments
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shareholders were treated to an unpleasant surprise by generics CEO Siggi Olafsson, who is said to......
(read more)December 7 - News, Stock Analysis - Comments
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down......
(read more)November 25 - Hedge Funds, News - Comments
The 1st US Circuit Court of Appeals has recently ruled in favor of AstraZeneca plc (ADR) (NYSE:AZN) and Ranbaxy Laboratories Limited (ADR) (OTCMKTS:RBXLY......
(read more)November 23 - News, Stock Analysis - Comments
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is alleged to have bought its way into boosting its sales in foreign countries including Russia,......
(read more)November 16 - News, Stock Analysis - Comments
It seems like Deja Vu all over again as pollsters and conventional wisdom were again proven wrong. Less than five months after the pro-Brexit side shocked......
(read more)November 9 - Market Movers, News - Comments
Although the non-farm payrolls for October came in worse than expected, at 161,000 versus the expected 175,000, volatility remains low on the Street as......
(read more)November 4 - Market Movers, News - Comments
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) will have to wait for a court ruling over its IP protection for its lifelong multiple sclerosis therapy......
(read more)November 1 - News - Comments
All three major indexes are in the red today, as the earnings results of several major companies including Apple Inc. (NASDAQ:AAPL) failed to meet expectations......
(read more)October 26 - Market Movers, News - Comments
Reports in the pharmaceutical space indicate that Teva Pharmaceutical Industries Ltd (NYSE:TEVA) might be planning to acquire South Korea biosimilar giant......
(read more)October 19 - News, Stock Analysis - Comments
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) recently entered into an exclusive agreement with Celltrion, Inc. to commercialize P10 and CT-P6, the......
(read more)October 7 - News, Stock Analysis - Comments
All three indexes have opened relatively flat this morning as traders brace for the major events this month, the FOMC meeting and the informal Russia/......
(read more)September 15 - Commodities, Market Movers, News - Comments
After Friday’s sharp drop in equity prices, more investors are keeping tabs on the market to see whether the recent interest rate fears will cause......
(read more)September 12 - Market Movers, News - Comments
Interest rate-sensitive financial stocks are in the spotlight today after previously-dovish Boston Federal Reserve President Eric Rosengren said that......
(read more)September 9 - Market Movers, News - Comments
Billionaire Larry Robbins‘ famed hedge fund Glenview Capital recently has submitted its 13F filing with SEC for the reporting period ended June......
(read more)September 3 - Hedge Funds, News - Comments
John Paulson is an American hedge fund manager and billionaire who founded his investment firm Paulson & Co in 1994 with only $2 million and one employee......
(read more)August 27 - Hedge Fund Analysis, Hedge Funds, News - Comments
Tiger Management was founded in 1980 by billionaire and legendary investor Julian Robertson, who later closed the fund to outside investors and now manages......
(read more)August 23 - Hedge Fund Analysis, Hedge Funds, News - Comments
London-based Cheyne Capital recently disclosed its U.S. equity portfolio via a 13F filing submitted with the SEC. Founded in 2000 by Jonathan Lourie and......
(read more)August 10 - Hedge Fund Analysis, Hedge Funds, News - Comments
Caught between a rock and a hard place due to the Brexit decision in June, the Bank of England announced today that it will cut interest rates and expand......
(read more)August 4 - Earnings Report, Market Movers, News - Comments
It’s been a relatively quiet morning on Wall Street as all three index futures are close to flat. Crude futures, which were originally down by 1......
(read more)July 13 - Market Movers, News - Comments
With the end of the quarter rapidly approaching, it seems that a short squeeze/bear market rally could be on deck as bargain hunters snap up stocks and......
(read more)June 28 - Market Movers, News - Comments
Crude prices are 1.5% lower today as traders are taking profits on yesterday’s run-up. Although most investors expect Britain to remain in the......
(read more)June 21 - Market Movers, News - Comments
On June 19, 2016, Epizyme Inc (NASDAQ:EPZM) presented a study update from its ongoing phase II trial in its lead oncology candidate, Tazemetostat. The......
(read more)June 20 - News, Stock Analysis - Comments
All three major index futures are in the red today as the market remains concerned about a potential Brexit. Fears that a Brexit might cause other nations......
(read more)June 13 - News - Comments
